Incorporation of a biocompatible nanozyme in cellular antioxidant enzyme cascade reverses huntington's like disorder in preclinical model

A Adhikari, S Mondal, M Das, P Biswas… - Advanced …, 2021 - Wiley Online Library
The potentiality of nano‐enzymes in therapeutic use has directed contemporary research to
develop a substitute for natural enzymes, which are suffering from several disadvantages …
被引用次数：44 相关文章

Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical Model

A Adhikari, S Mondal, M Das… - Advanced …, 2021 - pubmed.ncbi.nlm.nih.gov
The potentiality of nano-enzymes in therapeutic use has directed contemporary research to
develop a substitute for natural enzymes, which are suffering from several disadvantages …

Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical Model

A Adhikari, S Mondal, M Das, P Biswas… - Advanced Healthcare …, 2021 - hero.epa.gov
The potentiality of nano-enzymes in therapeutic use has directed contemporary research to
develop a substitute for natural enzymes, which are suffering from several disadvantages …

Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical Model.

A Adhikari, S Mondal, M Das, P Biswas… - Advanced Healthcare …, 2020 - europepmc.org
The potentiality of nano-enzymes in therapeutic use has directed contemporary research to
develop a substitute for natural enzymes, which are suffering from several disadvantages …
[PDF] archive.org

[PDF][PDF] Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical Model

A Adhikari, S Mondal, M Das, P Biswas, U Pal… - scholar.archive.org
Although, nano-enzymes have shown lots of promises in the management of several
diseases, two major concerns limit their clinical translation. Apart from the inherent toxicity of …
[PDF] academia.edu

[PDF][PDF] Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical Model

A Adhikari, S Mondal, M Das, P Biswas, U Pal… - academia.edu
Although, nano-enzymes have shown lots of promises in the management of several
diseases, two major concerns limit their clinical translation. Apart from the inherent toxicity of …
[PDF] researchgate.net

[PDF][PDF] Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical Model

A Adhikari, S Mondal, M Das, P Biswas, U Pal… - researchgate.net
Although, nano-enzymes have shown lots of promises in the management of several
diseases, two major concerns limit their clinical translation. Apart from the inherent toxicity of …

Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical Model

A Adhikari, S Mondal, M Das, P Biswas, U Pal… - bioRxiv, 2020 - biorxiv.org
The potentiality of nano-enzymes in therapeutic use has directed contemporary research to
develop a substitute for natural enzymes, which are suffering from several disadvantages …

Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical Model

A Adhikari, S Mondal, M Das, P Biswas, U Pal… - 2020 - europepmc.org
The potentiality of nano-enzymes in therapeutic use has directed contemporary research to
develop a substitute for natural enzymes, which are suffering from several disadvantages …